| View |
|
BR-1232
|
Botulinum Toxin Type A (from Clostridium botulinum)
|
Xeomin
|
50 Units
|
Powder For Solution For Injection (IM)
|
Prescription Drug (RX)
|
Type I Clear glass vial (box of 1's)
|
Muscle Relaxant
|
IDT Biologika GmbH
|
Germany
|
|
Merz Philippines Healthcare Inc.
|
Merz Philippines Healthcare Inc.
|
Automatic Renewal
|
30 August 2022
|
19 September 2027
|
| View |
|
BR-1233
|
Botulinum Toxin Type A (from Clostridium botulinum)
|
Xeomin
|
100 units
|
Powder For Solution For Injection (IM)
|
Prescription Drug (RX)
|
Type I Clear glass vial (box of 1's)
|
Muscle Relaxant
|
Merz Pharma GmbH & co. KGaA
|
Germany
|
|
Merz Philippines Healthcare Inc.
|
Merz Philippines Healthcare Inc.
|
Automatic Renewal
|
30 August 2022
|
19 September 2027
|
| View |
|
BR-1234
|
Botulinum Toxin* Type A (*from Clostridium botulinum)
|
Xeomin
|
50 Units
|
Powder for Solution for Injection (IM)
|
Prescription Drug (Rx)
|
Type I clear glass vial with bromobutyl rubber stopper and tamper-proof aluminium seal Box of 1's
|
Muscle Relaxant
|
Merz Pharma GmbH & Co. KGaA
|
Germany
|
N/A
|
Merz Philippines Healthcare Inc
|
|
Renewal
|
25 August 2022
|
19 September 2027
|
| View |
|
BR-1235
|
Isophane Insulin Human, Recombinant DNA
|
Jusline N
|
100 units/mL
|
Sterile Suspension For Injection ( Sc )
|
Prescription Drug (RX)
|
10mL USP Type I clear glass vial
|
Intermediate-acting Insulin
|
Gulf Pharmaceutical Industries ( Julphar )
|
UAE
|
|
Team Excel Distribution Inc.
|
Team Excel Distribution Inc.
|
Renewal
|
28 March 2023
|
14 March 2028
|
| View |
|
BR-1236
|
Regular Insulin Human, Recombinant DNA
|
Jusline R
|
100 units/mL
|
Sterile Suspension For Injection ( Sc )
|
Prescription Drug (RX)
|
10mL USP Type I clear glass vial
|
Short-acting Insulin
|
Gulf Pharmaceutical Industries ( Julphar )
|
UAE
|
|
Team Excel Distribution Inc.
|
Team Excel Distribution Inc.
|
Renewal
|
20 March 2023
|
14 March 2028
|
| View |
|
BR-1237
|
Neutral Insulin Human + Isophane Insulin Human, Recombinant DNA
|
Jusline 30/70
|
100 units/mL ( 30% as neutral insulin human/ 70% as isophane insulin human )
|
Sterile Suspension For Injection ( Sc )
|
Prescription Drug (RX)
|
10mL USP Type I clear glass vial
|
Intermediate-acting Insulin
|
Gulf Pharmaceutical Industries ( Julphar )
|
UAE
|
|
Team Excel Distribution Inc.
|
Team Excel Distribution Inc.
|
Renewal
|
22 March 2023
|
14 March 2028
|
| View |
|
BR-1240
|
Trastuzumab
|
Hertraz
|
150 mg
|
Powder for Concentrate for Solution for Infusion
(IV)
|
Prescription Drug (RX)
|
Each box contains: One 15 mL USP Type I glass vial with chlorobutyl rubber stopper and aluminum seal with blue flip-off cap + One 10 mL USP Type I glass vial (1.1% bacteriostatic water for injection as diluent)
|
Monoclonal Antibodies
|
Biocon Biologics India Limited
|
India
|
Mylan Laboratories Limited
|
Viatris Pharmaceuticals, Inc.
|
Viatris Pharmaceuticals, Inc.
|
Initial (from Monitored Release)
|
29 March 2023
|
05 October 2027
|
| View |
|
BR-1241
|
Trastuzumab
|
Hertraz
|
440 mg
|
Powder For Concentrate For Solution For Infusion (IV)
|
Prescription Drug (Rx)
|
Each box contains: One 50 mL USP Type I glass vial
Each box contains: One 50 mL USP Type I glass vial with chlorobutyl rubber stopper and aluminum seal with blue flip-off cap (drug product) + Two 15 mL (Net content: 10 mL) USP Type I Glass vial (1.1% bacteriostatic water for injection as diluent)
|
Monoclonal Antibodies
|
Biocon Biologics India Limited
|
India
|
Mylan Pharmaceuticals Private Limited
|
Viatris Pharmaceuticals, Inc
|
|
Initial (from Monitored Relase) (Correction)
|
22 April 2024
|
05 October 2027
|
| View |
|
BR-1243
|
Human Normal Immunoglobulin
|
Privigen
|
100 mg/mL (10% w/v)
|
Solution for Infusion (IV)
|
Prescription Drug (RX)
|
Type II glass vial x 50 mL, 100 mL and 200 mL
(Box of 1's)
|
-
|
CSL Behring AG
|
Switzerland
|
N/A
|
Zuellig Pharma Corporation
|
Zuellig Pharma Corporation
|
Renewal
|
28 June 2022
|
05 October 2027
|
| View |
|
BR-1244
|
Human Normal Immunoglobulin
|
Privigen
|
100 mg/mL (10% w/v)
|
Solution for Infusion (IV)
|
Prescription Drug (RX)
|
Type I glass vial x 25 mL (Box of 1's)
|
-
|
CSL Behring AG
|
Switzerland
|
N/A
|
Zuellig Pharma Corporation
|
Zuellig Pharma Corporation
|
Renewal
|
28 June 2022
|
05 October 2027
|
| View |
BR-1247_PI_01.pdf
|
BR-1247
|
Follitropin Alfa
|
Follitrope
|
75 IU / 0.15 mL
|
Solution for Injection (I.M./S.C.)
|
Prescription Drug (RX)
|
0.15 mL in 1 mL pre-filled glass syringe with elastomer rubber closure (Box of 1's).
|
-
|
LG Chem, Ltd.
|
Korea
|
N/A
|
Zuellig Pharma Corporation
|
Zuellig Pharma Corporation
|
Initial (from Monitored Release)
|
02 October 2023
|
06 October 2027
|
| View |
BR-1248_PI_01.pdf
|
BR-1248
|
Follitropin Alfa
|
Follitrope
|
150 IU / 0.3 mL
|
Solution for Injection (SC/IM)
|
Prescription Drug (RX)
|
1 mL (Net content: 0.3 mL) Pre-filled borosilicate glass
syringe with elastomer rubber stopper (Box of 1's)
|
-
|
LG Chem, Ltd.
|
Korea
|
N/A
|
Zuellig Pharma Corporation
|
Zuellig Pharma Corporation
|
Initial (from Monitored Release)
|
15 March 2023
|
06 October 2027
|
| View |
BR-1249_PI_01.pdf
|
BR-1249
|
Follitropin Alfa
|
Follitrope
|
225 IU/0.45 mL
|
Solution for Injection (SC/IM)
|
Prescription Drug (RX)
|
1 mL (Net content: 0. 45 mL) Pre-filled borosilicate glass syringe with elastomer rubber stopper (Box of 1's)
|
-
|
LG Chem, Ltd.
|
Korea
|
N/A
|
Zuellig Pharma Corporation
|
Zuellig Pharma Corporation
|
Initial (from Monitored Release)
|
15 March 2023
|
06 October 2027
|
| View |
BR-1250_PI_01.pdf
|
BR-1250
|
Follitropin Alfa
|
Follitrope
|
300 IU / 0.6 mL
|
Solution for Injection (SC/IM)
|
Prescription Drug (RX)
|
1 mL (Net content: 0.6 mL) Pre-filled borosilicate glass syringe with elastomer rubber stopper (Box of 1's)
|
-
|
LG Chem, Ltd.
|
Korea
|
N/A
|
Zuellig Pharma Corporation
|
Zuellig Pharma Corporation
|
Initial (from Monitored Release)
|
15 March 2023
|
06 October 2027
|
| View |
|
BR-1251
|
Heparin Sodium
|
None
|
1000 IU/mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (RX)
|
Type I clear glass vial x 5 mL (Box of 10's) Type I clear glass vial x 30 mL (Box of 20's)
|
-
|
AIN Medicare Sdn. Bhd.
|
Malaysia
|
N/A
|
Dega International Pharma Corp.
|
Dega International Pharma Corp.
|
Renewal
|
27 June 2022
|
06 August 2027
|
| View |
|
BR-1252
|
Nimotuzumab
|
TheraCIM
|
50 mg/10 mL
|
Solution For IV Infusion
|
Prescription Drug (RX)
|
EP Type I Glass Vial
|
-
|
Center of Molecular Immunology (CIM)
|
Cuba
|
(For) Innogene Kalbiotech Pte. Ltd.- Singapore
|
Globo Asiatico Ent. Inc.
|
Globo Asiatico Ent. Inc.
|
Automatic Renewal
|
14 October 2022
|
28 September 2027
|
| View |
|
BR-1254
|
Menotrophin
|
Humog 150
|
150 IU
|
Solution for Injection
|
Prescription Drug (RX)
|
Box of 1's
|
GONADOTROPHIN
|
Bharat Biotech International Ltd.
|
India
|
|
BSV Bioscience Philippines Inc.
|
Sandoval Distributors & Pharmacy
|
Automatic Renewal
|
27 December 2022
|
04 January 2028
|
| View |
|
BR-1255
|
Menotrophin
|
Humog 75
|
75 IU
|
Solution for Injection
|
Prescription Drug (RX)
|
Box of 1's
|
GONADOTROPHIN
|
Bharat Biotech International Ltd.
|
India
|
|
BSV Bioscience Philippines Inc.
|
Sandoval Distributors & Pharmacy
|
Automatic Renewal
|
16 December 2022
|
04 January 2028
|
| View |
|
BR-1259
|
Chorionic Gonadotrophin
|
Hucog-5,000 Hp
|
5,000 IU
|
Solution For Injection/ 5000 I.U.
|
Prescription Drug (RX)
|
Box of 1's
|
Gonadotropins
|
Bharat Serums and Vaccine Limited
|
India
|
|
BSV Bioscience Philippines Inc.
|
Sandoval Distributors & Pharmacy
|
Automatic Renewal
|
13 December 2022
|
26 January 2028
|
| View |
|
BR-1261
|
Urofollitropin
|
Foliculin -75 HP
|
75 IU
|
Lyophilized Powder for Solution for Injection (IM/SC)
|
Prescription Drug (RX)
|
Packaging: 2 mL USP Type I clear glass tubular vial with bromobutyl rubber bung and brown aluminum flip-off seal + 1 mL ampoule of diluent (0.9% Sodium Chloride Solution for Injection) (Box of 1's)
|
Gonadotropins
|
Bharat Serums and Vaccines Limited
|
India
|
N/A
|
BSV Bioscience Phils. Inc.
|
Sandoval Distributors, Inc.
|
Initial
|
18 February 2022
|
05 March 2026
|